Sign in
TerminatedPhase 3

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Key facts

Who runs it
The University of Texas Medical Branch, Galveston
Where
Austin and Galveston, United StatesSee the 2 sites
Trial code
Status
Terminated
Phase
Phase 3
People taking part
453 people enrolled
Started
21 Nov 2017
Ended
22 Apr 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Hydrochlorothiazide 50mg Tablet
  • Placebo Tablet
Record updated
14 July 2026
Why it stopped
Futility of the study

Who can take part

Age
18 years to 50 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Maternal age ≥ 18 years and <50 years
  • Diagnosis of gestational hypertension* or preeclampsia\^ at any time during pregnancy, labor or postpartum; defined as isolated systolic BP of 140 mm Hg or greater, a diastolic BP of 90 mm Hg or greater, or both) or \^ defines as new-onset hypertension plus new-onset proteinuria, or in the absence of proteinuria, preeclampsia is diagnosed as hypertension in association with thrombocytopenia (platelet count less than 100,000/microliter), impaired liver function (elevated blood levels of liver transaminases to twice the normal concentration), the new development of renal insufficiency (elevated serum creatinine greater than 1.1 mg/dL or a doubling of serum creatinine in the absence of other renal disease), pulmonary edema, or new-onset cerebral or visual disturbances.)

Who cannot take part

  • Subject requiring antihypertensive therapy at time of screening
  • Planned discharge with oral anti-hypertensive medication
  • Contraindication to hydrochlorothiazide (advanced renal failure or anuria, hypersensitivity to sulfonamides)
  • Pre-gestational diabetes
  • Subject not able to follow up postpartum
  • Lactose intolerance

Where in United States

  • St. David's North Austin Medical CenterAustin, United States
  • University of Texas Medical BranchGalveston, United States

About the trial

What the trial wants to find out

Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.

The 2 groups in the trial

  • Hydrochlorothiazide 50mg TabletExisting treatment, for comparison

    Hydrochlorothiazide 50 mg per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum.

  • Placebo TabletPlacebo, for comparison

    Placebo per os once daily as soon as the subjects can tolerate sips of water after delivery and for fourteen days postpartum

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide: a Randomized Clinical Trial
Record updated
14 July 2026